To conclude, our study identifies the lncRNA H19 as a critical determiner of cellular IRS1 levels and during diabetes, decreased levels of this lncRNA promotes an inhibition in IRS1 gene expression, possibly due to increased deacetylation mediated by HDAC6 in the skeletal muscle. This evidence concerns the gene IRS1 and diabetes mellitus.